Guardant Health
GH
#2639
Rank
โ‚ฌ4.61 B
Marketcap
37,43ย โ‚ฌ
Share price
-5.71%
Change (1 day)
119.43%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚ฌ1.49 Billion

According to Guardant Health 's latest financial reports the company's total liabilities are โ‚ฌ1.49 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Guardant Health - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ1.56 B6.07%
2023-12-31โ‚ฌ1.47 B1.91%
2022-12-31โ‚ฌ1.44 B4.92%
2021-12-31โ‚ฌ1.37 B84.87%
2020-12-31โ‚ฌ0.74 B628.49%
2019-12-31โ‚ฌ0.10 B87.3%
2018-12-31โ‚ฌ54.59 M90.79%
2017-12-31โ‚ฌ28.61 M-18.37%
2016-12-31โ‚ฌ35.05 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ0.42 B-71.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.27 B-14.78%๐Ÿ‡บ๐Ÿ‡ธ USA